Skip to main content
BIO.B logo

Bio-Rad Laboratories, Inc.

BIO.BNYSEHealthcareMedical Devices

$364.15Today:- (-)1Y +27.83%

As of Oct 15, 2026 close

Market cap
$9.76B
P/E (TTM)
43.90
Forward P/E
63.28
Dividend yield
-
52-week range
$244.54$365.08
Volume (live)
-
Avg. volume (3M)
7

Bio-Rad Laboratories (BIO.B) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Bio-Rad Laboratories had a P/E ratio of 10.81, return on equity of 10.8% (up from -24.1%), debt-to-equity of 0.19 (down from 0.21) and a current ratio of 5.62 (down from 6.48). A current ratio of 5.62 means current assets exceed current liabilities.

Bio-Rad Laboratories Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio10.81---5.284.55
P/S Ratio3.183.583.524.457.686.81
P/B Ratio1.101.401.071.301.641.76
Price/Tangible Book1.231.571.171.401.721.85
Price/FCF21.9231.7143.08152.7041.8836.41
Price/OCF15.4320.1725.0764.1033.5229.65
Enterprise Value Ratios
EV/Revenue3.173.493.394.287.306.61
EV/EBITDA18.9720.3017.6819.3430.3730.07
EV/EBIT30.7630.9424.7424.8437.7739.96
EV/FCF21.8630.9041.46146.9339.8135.34
Profitability & Returns
Return on Equity (ROE)10.84%-24.09%-6.94%-31.14%36.11%48.79%
Return on Assets (ROA)1.67%1.67%1.77%1.93%2.29%2.51%
Return on Invested Capital (ROIC)2.99%3.90%4.12%4.34%3.98%4.54%
Return on Capital Employed (ROCE)2.60%3.30%3.10%3.70%3.30%3.40%
Leverage & Solvency Ratios
Debt/Equity0.190.210.160.140.020.02
Debt/EBITDA2.782.692.442.050.300.37
Debt/FCF3.704.756.4417.010.420.47
Liquidity Ratios
Current Ratio5.626.485.835.552.923.39
Quick Ratio3.894.554.034.041.902.24
Efficiency Ratios
Asset Turnover0.260.240.210.180.190.24
Inventory Turnover1.651.521.651.912.111.88
Yield & Distribution Ratios
Earnings Yield9.25%-20.08%-6.78%-29.11%18.96%21.99%
FCF Yield4.56%3.15%2.32%0.66%2.39%2.75%
Buyback Yield3.31%3.41%1.93%1.40%-0.16%0.08%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Bio-Rad Laboratories Financial Ratios

What is Bio-Rad Laboratories's P/E ratio?

Bio-Rad Laboratories's P/E ratio was 10.81 for fiscal 2025 (period ended Dec 31, 2025).

What is Bio-Rad Laboratories's return on equity?

Bio-Rad Laboratories's return on equity (ROE) was 10.8% for fiscal 2025 (period ended Dec 31, 2025). It was -24.1% a year earlier.

What is Bio-Rad Laboratories's debt-to-equity ratio?

Bio-Rad Laboratories's debt-to-equity ratio was 0.19 for fiscal 2025 (period ended Dec 31, 2025). It was 0.21 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition